Legacy Healthcare's Cinainu® Receives FDA Breakthrough Therapy Designation for Alopecia Areata in Adults, Adolescents and Children Aged 2 Years and Older PR Newswire (Press Release) 14:20 Tue, 13 Oct
Long-term baricitinib efficacy, safety upheld in adolescent alopecia Dermatology Advisor 18:06 Fri, 16 Oct Science
